The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Loss of HtrA1-induced attenuation of TGF-β signaling in fibroblasts might not be the main mechanism of CARASIL pathogenesis
Open accessAbstract
Loss of HtrA1-induced attenuation of TGF-β signaling in fibroblasts might not be the main mechanism of CARASIL pathogenesisIn their contribution to PNAS, Beaufort et al. demonstrate that high temperature requirement protein A1 (HtrA1) facilitates TGF-β signaling through processing latent TGF-β binding protein 1 (LTBP-1) (1).Then the authors suggest the down-regulation of TGF-β signaling by lack of HtrA1-mediated LTBP-1 processing as a key mechanism underlying pathogenesis of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) (1).We applaud the authors for their careful work about HtrA1 but would like to point out that they only studied fibroblasts (FBs), and their data do not support a causative role of this novel mechanism for the pathogenesis of CARASIL.For CARASIL patients, the main pathology falls on the small penetrating arteries, with lack of vascular smooth muscle cells (VSMCs) in the media and intense adventitial fibrosis (2).Loss of VSMCs is the primary feature of CARASIL, followed by deposition of the granular material in the media and fibrosis of the arterial wall (2, 3).Arterial fibrosis results in the deficiency of contraction of the arteries,
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
HTRA1 is highly expressed in vascular mural cells, particularly SMCs.
“Interestingly, HTRA1 is highly expressed in vascular mural cells, particularly SMCs (371), and its encoded protein HTRA1 plays a key role in facilitating TGF𝛃 signaling through processing latent TGF𝛃 binding protein 1 (LTBP-1) (55).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [371]
Citations
Cites
Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease
Hara, K., Shiga, A., Fukutake, T., Nozaki, H., Miyashita, A., Yokoseki, A., Kawata, H., Koyama, A., Arima, K., Takahashi, T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0801560 · Cited by 460
Tikka, S., Baumann, M., Siitonen, M., Pasanen, P., Pöyhönen, M., Myllykangas, L., Viitanen, M., Fukutake, T., Cognat, E., Joutel, A., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12181 · Cited by 189
Beaufort, N., Scharrer, E., Kremmer, E., Lux, V., Ehrmann, M., Huber, R., Houlden, H., Werring, D., Haffner, C., & Dichgans, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418087111 · Cited by 145
Flagged first, then by citations
Research works printed but not linked: 2
- 10.1046/j.1440-1789.2003.00519.x · DOI
- 10.1096/fj.03-1273rev · DOI · Paper page
Cited by
Sorted by citations
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Metadata
- Authors
- Liu, J., Dong, F., & Hoh, J.
- Affiliations
- Shandong University (CN)
- Yale University (US)
- ORCID
- Liu, Ju
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-03-13
- Volume
- 112
- Issue
- 14
- Pages
- E1693-E1693
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4394265
- OpenAlex
- W1972923119
- Cited by
- 9
- References
- 3
- Citations by year
- 2025: 2 · 2023: 1 · 2022: 1 · 2019: 2 · 2018: 1 · 2015: 2
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- HTRA1, TGF-beta signaling, CARASIL, fibroblasts, pathogenesis, neurodegeneration, protein quality control, molecular chaperones
- MeSH terms
- Alopecia, Animals, Cerebral Infarction, Humans, Serine Endopeptidases, Spinal Diseases, Transforming Growth Factor beta1, Latent TGF-beta Binding Proteins, Leukoencephalopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review